Inventor · disambiguated record
Hakan Eriksson
Also filed as: ERIKSSON HAAKAN · ERIKSSON HAAKAN NILS · ERIKSSON HAKAN
7 granted patents·9 pending applications·234 citations·filing 1989–2020
87Inventor score
Files withASTRAZENECA AB7AMERICAN CYANAMID CO2ERICSSON TELEFON AB L M1ERIKSSON HAKAN1EURO DIAGNOSTICA AB1
Top patents by PatentIndex Score
16 records- 0192US5266333AWater dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormoneAMERICAN CYANAMID CO·Filed 1989·Granted Nov 30, 1993·145 cites·12 claims
- 0270US5936061AUse of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solutionFiled 1996·Granted Aug 10, 1999·32 cites·31 claims
- 0368US10772890B2Use of myeloperoxidase (MPO) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (MSA) 938ASTRAZENECA AB·Filed 2018·Granted Sep 15, 2020·0 cites·2 claims
- 0466US2020405724A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (msa) 938ASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 0562US8360233B2Adjustment device for the adjustment of belts of belt conveyorsSANDVIK INTELLECTUAL PROPERTY·Filed 2009·Granted Jan 29, 2013·5 cites·13 claims
- 0660US2009053176A1New Combination 937ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0760US2009054468A1New Use 938ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0857US2014221400A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2013·Application pending·0 cites
- 0955US2013059870A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 1052US6151482AOperation and maintenance link for antenna equipmentERICSSON TELEFON AB L M·Filed 1997·Granted Nov 21, 2000·31 cites·56 claims
- 1151US2011207755A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2011·Application pending·0 cites
- 1247US2010291705A1Antigen exposing micelle and unordered aggregateEURO DIAGNOSTICA AB·Filed 2008·Application pending·0 cites
- 1344US5108617AMethod of using zeolites for adsorbing detergentsERIKSSON HAKAN·Filed 1991·Granted Apr 28, 1992·15 cites·6 claims
- 1440US2003087753A1System for microbial control of a fluidHJERTMAN BIRGER·Filed 2002·Application pending·0 cites
- 1538US5456922AWater dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormoneAMERICAN CYANAMID CO·Filed 1993·Granted Oct 10, 1995·6 cites·12 claims
- 1624US2001040933A1Signal filteringFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hakan Eriksson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →